Navigation Links
FutureFuel Corp. Declares Dividend
Date:8/17/2010

ST. LOUIS, Aug. 17 /PRNewswire-FirstCall/ -- On August 17, 2010, FutureFuel Corp. (OTC Bulletin Board: FTFL) filed a Form 8K with the Securities and Exchange Commission declaring a special cash dividend of $0.20 per share.

The board of directors of FutureFuel Corp. (the "Company") has declared a special cash dividend of U.S. $0.20 per share on the Company's common stock, with a record date of September 14, 2010.

The dividend is payable September 30, 2010.

FutureFuel Corp. was created in 2005 as a special purpose acquisition vehicle to acquire companies and make a notable impact in the biofuel and fuel industries.  In October 2006, the Company purchased FutureFuel Chemical Company (formerly named "Eastman SE, Inc."), the owner and operator of a chemical and biodiesel manufacturing facility located near Batesville, Arkansas.  Since then, the Company has worked to become a leader in the U.S. biofuel industry, while maintaining the Batesville facility's status as a world-class specialty chemical manufacturer.


'/>"/>
SOURCE FutureFuel Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. FutureFuel Corp. Declares Dividend
2. CRH Medical Corp. Joins OTCQX
3. IGEN Networks Corp. announces new Board member and the cancellation of three million shares for return to treasury
4. Cobalis Corp. Appoints Martin Marion as Chief Executive Officer
5. Spectros Corp. Deep-Monitoring Continuum Noninvasive Cerebral Oxygenation Sensors
6. DiscoveRx Corp. & Jubilant Biosys Limited Announce Co-Marketing Agreement for Screening Services
7. Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director
8. AvidBiotics Corp. Granted Key U.S. and European Patents on Unique Protein Modification Platform
9. Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
10. BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
11. Thermogenesis Corp. to Announce First Quarter Fiscal 2010 Results on November 5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 18, 2017 , ... LabRoots , the leading provider ... world, was today awarded the "Best Science & Technology Social Networking Service 2016" ... decided upon by a dedicated team of researchers and analysts. , The 2016 ...
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. ... DCVax® personalized immune therapies for operable and inoperable solid ... , Chief Technical Officer of NW Bio, will present ... 19, 2017, at the Hyatt Regency Hotel in ... will chair the session entitled "New Therapeutic Approaches – ...
(Date:1/18/2017)... 2017 According to a new market research report "In ... Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global ... 739.9 Million by 2021 from USD 557.1 Million in 2016, growing at a ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic (IVD) ... mergers and acquisitions (M&A), and Kalorama Information expects that ... acquisitions have been shifting. Generally, uncertainty in reimbursement and ... the U.S. has changed the acquisitions landscape. Instead of ... in companies buying partners outside of their home country ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
Breaking Biology News(10 mins):